Life-threatening arrhythmias with autosomal recessive TECRL variants

Multiallelic rare variants support an oligogenic origin of sudden cardiac death in the young

(2020) Hager Jaouadi et al.   HERZ

Novel Variants in TECRL Cause Recessive Inherited CPVT Type 3 with Severe and Variable Clinical Symptoms

(2020) Alexander Moscu‐Gregor et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family

(2019) Lijian Xie et al.   European Journal of Medical Genetics

Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry

(2019) Lia Crotti et al.   EUROPEAN HEART JOURNAL

Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis

(2017) Jinhee Ahn et al.   PLoS One

TECRL , a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT

(2016) Harsha D Devalla et al.   EMBO Molecular Medicine

Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia

(2016) Ida S. Leren et al.   HEART RHYTHM

A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia

(2016) Belinda Gray et al.   HEART RHYTHM

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Phenotype Variability in Patients Carrying KCNJ2 Mutations

(2012) Hiromi Kimura et al.   Circulation-Cardiovascular Genetics

Not All Beta-Blockers Are Equal in the Management of Long QT Syndrome Types 1 and 2

(2012) Priya Chockalingam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nadolol Block of Nav1.5 Does Not Explain Its Efficacy in the Long QT Syndrome

(2011) Alessandra Besana et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY